Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success

International Archives of Allergy and Immunology

Volumn 132, Issue 3, 2003, Pages 196-209

  Schüpbach, Jörg ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antiretroviral treatment monitoring; HIV infection; HIV RNA; p24 antigen; Viral load

Indexed keywords

ANTIBODY; ANTIGEN P24; ANTIVIRUS AGENT; BIOLOGICAL MARKER; BUFFER; CD4 ANTIGEN; INDINAVIR; ISOPROPAMIDE IODIDE; VIRUS PROTEIN; VIRUS RNA;

ADULT; ANTIGEN DETECTION; BIOLOGICAL MONITORING; CHILD; CIRCADIAN RHYTHM; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DENATURATION; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; HEAT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LYSIS; PEDIATRICS; PLASMA; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SAMPLING; STANDARDIZATION; T LYMPHOCYTE; TREATMENT OUTCOME; VIREMIA; VIRUS DETECTION; VIRUS PARTICLE; VIRUS STRAIN;

ANTI-HIV AGENTS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TREATMENT FAILURE;

EID: 0344629362     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074552     Document Type: Review

References (68)

1. O'Brien WA, Hartigan PM, Martin D, et al: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-431.
2. Egger M, Hirschel B, Francioli P, et al: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997;315:1194-1199.
3. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
4. Staszewski S, Miller V, Sabin C, et al: Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS 1999;13:951-956
5. Autran B, Carcelain G, Li TS, et al: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116
6. Pakker NG, Notermans DW, de Boer RJ, et al: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat Med 1998;4:208-214.
7. Gorochov G, Neumann AU, Kereveur A, et al: Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998;4:215-221.
8. McCune JM, Loftus R, Schmidt DK, et al: High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998;101:2301-2308.
9. Douek DC, McFarland RD, Keiser PH, et al: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-695.
10. Wei X, Ghosh SK, Taylor ME, et al: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
11. Neumann AU, Tubiana R, Calvez V, et al: HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. AIDS 1999;13:677-683.
12. Piatak M Jr, Saag MS, Yang LC, et al: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754
13. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
14. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
15. O'Brien TR, Blattner WA, Waters D, et al: Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-110.
16. Coombs RW, Welles SL, Hooper C, et al: Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups. J Infect Dis 1996;174:704-712.
17. Saag MS, Holodniy M, Kuritzkes DR, et al: HIV viral load markers in clinical practice. Nat Med 1996;2:625-629.
18. O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD: Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 1997;126: 939-945.
19. Farzadegan H, Henrard DR, Kleeberger CA, et al: Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:448-455.
20. Henrard DR, Phillips JF, Muenz LR, et al: Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-558.
21. Lathey JL, Hughes MD, Fiscus SA, et al: Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis 1998;177:617-624.
22. Yerly S, Perneger TV, Hirschel B, et al: A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study. Arch Intern Med 1998;158:247-252.
23. Lange JM, Paul DA, de Wolf F, Coutinho RA, Goudsmit J: Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection. AIDS 1987;1:15-20.
24. de Wolf F, Goudsmit J, Paul DA, et al: Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) 1987;295:569-572.
25. Pedersen C, Nielsen CM, Vestergaard BF, Gerstoft J, Krogsgaard K, Nielsen JO: Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. Br Med J (Clin Res Ed) 1987;295:567-569.
26. Hammer SM: Advances in antiretroviral therapy and viral load monitoring. AIDS 1996;10: S1-11.
27. Miles SA, Balden E, Magpantay L, et al: Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med 1993;328:297-302.
28. Gutierrez M, Vallejo A, Soriano V: Enhancement of HIV antigen detection after acid dissociation of immune complexes is associated with loss of specificity. Vox Sang 1995;68:132-133.
29. Schupbach J, Boni J: Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. J Virol Methods 1993;43:247-256.
30. Steindl F, Armbruster C, Pierer K, Purtscher M, Katinger HWD: A simple and robust method for the complete dissociation of Hiv-1 P24 and other antigens from immune complexes in serum and plasma samples. J Immunol Methods 1998;217:143-151.
31. Giacomini M, McDermott JL, Giri AA, Martini I, Lillo FB, Varnier OE: A novel and innovative quantitative kinetic software for virological colorimetric assays. J Virol Methods 1998;73:201-209.
32. Schupbach J, Boni J, Tomasik Z, Jendis J, Seger R, Kind C: Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis 1994;170:318-324.
33. Dickover RE, Dillon M, Gillette SG, et al: Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994;170:1279-1284.
34. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ: Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods 1989;125:279-285.
35. Schupbach J, Flepp M, Pontelli D, Tomasik Z, Luthy R, Boni J: Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 1996;10:1085-1090.
36. Schupbach J, Boni J, Bisset LR, et al: HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J Acquir Immune Defic Syndr 2003;33:292-299.
37. Jennings CL, et al: A Comparison of two non-RNA-based assays for the quantitation of HIV (poster). ICAAC, Chicago, 2003.
38. Coffin JM: Retroviridae: The viruses and their replication; in Fields BN, Knipe DM, Howley PM (eds): Virology, ed 3. Philadelphia, Lippincott-Raven, 1996, pp 1767-1847.
39. Boni J, Opravil M, Tomasik Z, et al: Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 P24 antigen assay with heat-denatured plasma. AIDS 1997;11:F47-F52.
40. Nadal D, Böni J, Kind C, et al: Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric HIV-1 infection. J Infect Dis 1999;180:1089-1095.
41. Ledergerber B, Flepp M, Boni J, et al: Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: Comparison with viral RNA measurement. J Infect Dis 2000;181:1280-1288.
42. Schüpbach J, Boni J, Flepp M, Tomasik Z, Joller H, Opravil M: Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: An inexpensive alternative to tests for viral RNA. J Med Virol 2001;65:225-232.
43. Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J: Prognostic value of heat-denatured HIV-1 p24 antigen and correlation with plasma HIV-1 viral load and CD4+ T-lymphocyte level in adults. J Infect Dis 2002;186:1181-1185.
44. Pascual A, Cachafeiro A, Funk ML, Fiscus SA: Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J Clin Microbiol 2002;40:2472-2475.
45. Ribas SG, Ondoa P, Schupbach J, van der Groen G, Fransen K: Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. J Virol Methods 2003;113:29-34.
46. Clark SJ, Saag MS, Decker WD, et al: High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991;324:954-960.
47. Daar ES, Moudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-964.
48. Graziosi C, Pantaleo G, Butini L, et al: Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993;90:6405-6409
49. Koup RA, Safrit JT, Cao Y, et al: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
50. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L: Biological and virologic characteristics of primary HIV infection. Ann Intern Med 1998;128:613-620.
51. Fiebig EW, Wright DJ, Rawal BD, et al: Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871-1879.
52. Embretson J, Zupancic M, Ribas JL, et al: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-362.
53. Pantaleo G, Graziosi C, Demarest JF, et al: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-358.
54. Heath SL, Tew JG, Tew JG, Szakal AK, Burton GF: Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995;377:740-744.
55. Perelson AS, Essunger P, Cao YZ, et al: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997;387:188-191.
56. Zhang LQ, Dailey PJ, He T, et al: Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J Virol 1999;73:855-860.
57. Pantaleo G, Cohen OJ, Schacker T, et al: Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection - Implications for antiviral therapy. Nat Med 1998;4:341-345.
58. Jurriaans S, Van Gemen B, Weverling GJ, et al: The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course? Virology 1994;204:223-233.
59. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993;262:1011-1018.
60. Boni J: PCR detection of HIV. Methods Mol Biol 1996;50:93-107.
61. Lyamuya E, Bredberg-Raden U, Massawe A, et al: Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 1996;12:421-426.
62. Vandamme AM, Schmit JC, Van Dooren S, et al: Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Acquir Immune Defic Syndr 1996;13:127-139.
63. Schupbach J, Boni J, Flepp M, Tomasik Z, Joller H, Opravil M: Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: An inexpensive alternative to tests for viral RNA. J Med Virol 2001;65:225-232.
64. Bürgisser P, Vernazza P, Flepp M, et al: Performance of five different assays for the quantification of viral load in subjects infected with various subtypes of HIV-1. J Acquir Immune Defic Syndr 2000;23:138-144.
65. Pyra H, Boni J, Schupbach J: Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci USA 1994;91:1544-1548.
66. Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, Chaisilwatana P: p24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol 2003;41:1016-1022.
67. Schüpbach J: Human imunodeficiency viruses; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds): Manual of Clinical Microbiology. Washington, ASM Press, 1999, pp 847-870.
68. Schüpbach J, Tomasik Z, Nadal D, et al: Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Int J Antimicrob Agents 2000;16:441-445.